Loading...

Interactive visualization of extracted data from the MONALEESA-3 study regarding Health-Related Quality of Life (HRQOL).

Study Design & Groups

Randomized comparison of Ribociclib + Fulvestrant vs. Placebo + Fulvestrant.

Time to Deterioration (Hazard Ratios)

Hazard Ratios < 1 favor Ribociclib. Error bars represent 95% CI.

Baseline Scores (Mean ± SD)

Comparison of baseline QOL scores between groups.

Effect Magnitude (1 / Hazard Ratio)

Visualizing the relative benefit magnitude. Higher values indicate stronger benefit for Ribociclib.

Population Distribution

Sample size distribution across the two study arms (2:1 Randomization).

Evidence Provenance Map

Mapping extracted metrics to their source quotes in the document.

Appendix: Raw Data & Provenance